Concept Medical enrols first patient in balloon angioplasty trial
The announcement followed the company receiving Investigational Device Exemption (IDE) from the US Food and Drug Administration (FDA).
Boehringer Ingelheim announces Phase III schizophrenia failures
Ocugen doses first subject in Phase I trial of diabetic macular oedema treatment
Avacta Therapeutics reports data from trial of AVA6000 for salivary gland cancer
European supergroup launches to tackle diversity in clinical trials
OS Therapies’s HER2 therapy prevents lung cancer recurrence in 33% patients
Analysis
View More
Themes
View MoreJP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline
Jazz Pharmaceuticals plans to expand indications for two oncology drugs, namely zanidatamab and Zepzelca.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic
Respite from rising trial costs is a distant dream in 2025
Insilico announces positive results from Phase I trials of AI-designed ISM5411
Study finds restrictive clinical trial criteria excludes Lyme disease patients